Beyond its immunomodulatory effects, LL-37 promotes angiogenesis in the skin by inducing vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs), contributing to the progression of various cancers, including skin cancer [12,13]. This evidence concerns the gene VEGFA and skin cancer.